{"id":"https://openalex.org/W7052897272","doi":null,"title":"Steigerung der Effektivit\u00e4t antik\u00f6rperbasierter Immuntherapien bei malignen Erkrankungen durch Blockade der CD47-SIRP\u03b1-Interaktion","display_name":"Steigerung der Effektivit\u00e4t antik\u00f6rperbasierter Immuntherapien bei malignen Erkrankungen durch Blockade der CD47-SIRP\u03b1-Interaktion","alternate_titles":[],"publication_year":2023,"publication_date":"2023-01-01","ids":{"openalex":"https://openalex.org/W7052897272"},"language":"de","primary_location":{"id":"pmh:oai:macau.uni-kiel.de:macau_mods_00004137","doi":null,"is_oa":true,"landing_page_url":"https://macau.uni-kiel.de/receive/macau_mods_00004137","pdf_url":"https://macau.uni-kiel.de/servlets/MCRFileNodeServlet/macau_derivate_00005296/Baumann-Niklas-ZuD_druckreif_final.pdf","source":{"id":"https://openalex.org/S4306402453","display_name":"MACAU: Open Access Repository of Kiel University (University Library Kiel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32021983","host_organization_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","host_organization_lineage":["https://openalex.org/I32021983"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"dissertation"},"parent_works":[],"lineage":["https://openalex.org/W7052897272"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://macau.uni-kiel.de/servlets/MCRFileNodeServlet/macau_derivate_00005296/Baumann-Niklas-ZuD_druckreif_final.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068485002","display_name":"Niklas Baumann","orcid":"https://orcid.org/0000-0002-4864-5022","observed_orcids":["https://orcid.org/0000-0002-4864-5022"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Baumann, Niklas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5068485002"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd47-blockade","display_name":"CD47 blockade","score":0.7269999980926514},{"id":"https://openalex.org/keywords/antibody-based-immunotherapy","display_name":"antibody-based immunotherapy","score":0.777999997138977},{"id":"https://openalex.org/keywords/cd38","display_name":"CD38","score":0.8560000061988831},{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.8199999928474426},{"id":"https://openalex.org/keywords/retinoic-acid","display_name":"retinoic acid","score":0.8209999799728394},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9909999966621399},{"id":"https://openalex.org/keywords/panitumumab","display_name":"panitumumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.6159999966621399},{"id":"https://openalex.org/keywords/phagocytosis","display_name":"phagocytosis","score":0.7910000085830688},{"id":"https://openalex.org/keywords/tumor-cell-lysis","display_name":"tumor cell lysis","score":0.5070000290870667},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.3569999933242798},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.3310000002384186}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43700000643730164},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4050000011920929},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.35530000925064087},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3328000009059906},{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.3206999897956848},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.2827000021934509},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.24819999933242798},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24580000340938568},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.24169999361038208},{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.22419999539852142}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:macau.uni-kiel.de:macau_mods_00004137","doi":null,"is_oa":true,"landing_page_url":"https://macau.uni-kiel.de/receive/macau_mods_00004137","pdf_url":"https://macau.uni-kiel.de/servlets/MCRFileNodeServlet/macau_derivate_00005296/Baumann-Niklas-ZuD_druckreif_final.pdf","source":{"id":"https://openalex.org/S4306402453","display_name":"MACAU: Open Access Repository of Kiel University (University Library Kiel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32021983","host_organization_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","host_organization_lineage":["https://openalex.org/I32021983"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"dissertation"}],"best_oa_location":{"id":"pmh:oai:macau.uni-kiel.de:macau_mods_00004137","doi":null,"is_oa":true,"landing_page_url":"https://macau.uni-kiel.de/receive/macau_mods_00004137","pdf_url":"https://macau.uni-kiel.de/servlets/MCRFileNodeServlet/macau_derivate_00005296/Baumann-Niklas-ZuD_druckreif_final.pdf","source":{"id":"https://openalex.org/S4306402453","display_name":"MACAU: Open Access Repository of Kiel University (University Library Kiel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32021983","host_organization_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","host_organization_lineage":["https://openalex.org/I32021983"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"dissertation"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7052897272.pdf","grobid_xml":"https://content.openalex.org/works/W7052897272.grobid-xml"},"referenced_works_count":126,"referenced_works":["https://openalex.org/W14274566","https://openalex.org/W46942601","https://openalex.org/W206701898","https://openalex.org/W1493742659","https://openalex.org/W1494640119","https://openalex.org/W1512026049","https://openalex.org/W1570686199","https://openalex.org/W1585625390","https://openalex.org/W1593975549","https://openalex.org/W1770942365","https://openalex.org/W1820985264","https://openalex.org/W1840824980","https://openalex.org/W1841458780","https://openalex.org/W1844667028","https://openalex.org/W1963778872","https://openalex.org/W1964747353","https://openalex.org/W1965205681","https://openalex.org/W1966067305","https://openalex.org/W1973919081","https://openalex.org/W1981886418","https://openalex.org/W1983494459","https://openalex.org/W1988142400","https://openalex.org/W1991180616","https://openalex.org/W1991656907","https://openalex.org/W1992252296","https://openalex.org/W1993024082","https://openalex.org/W1994957566","https://openalex.org/W1999283861","https://openalex.org/W2002547764","https://openalex.org/W2005044790","https://openalex.org/W2011261569","https://openalex.org/W2015567053","https://openalex.org/W2018912432","https://openalex.org/W2025012298","https://openalex.org/W2028658315","https://openalex.org/W2030522563","https://openalex.org/W2031089532","https://openalex.org/W2031209863","https://openalex.org/W2036447451","https://openalex.org/W2039578184","https://openalex.org/W2039950956","https://openalex.org/W2043228552","https://openalex.org/W2048954270","https://openalex.org/W2050217807","https://openalex.org/W2050754173","https://openalex.org/W2051133499","https://openalex.org/W2054540776","https://openalex.org/W2057796048","https://openalex.org/W2057936669","https://openalex.org/W2064047613","https://openalex.org/W2068125497","https://openalex.org/W2074125587","https://openalex.org/W2075097399","https://openalex.org/W2077291494","https://openalex.org/W2082849642","https://openalex.org/W2083435401","https://openalex.org/W2084875238","https://openalex.org/W2087490087","https://openalex.org/W2087638630","https://openalex.org/W2091241899","https://openalex.org/W2095201384","https://openalex.org/W2096428863","https://openalex.org/W2096626380","https://openalex.org/W2102369421","https://openalex.org/W2103746815","https://openalex.org/W2105244471","https://openalex.org/W2114571489","https://openalex.org/W2121760861","https://openalex.org/W2122885616","https://openalex.org/W2124467421","https://openalex.org/W2125894404","https://openalex.org/W2133105825","https://openalex.org/W2133205391","https://openalex.org/W2134057839","https://openalex.org/W2134989772","https://openalex.org/W2139418176","https://openalex.org/W2139419109","https://openalex.org/W2141502099","https://openalex.org/W2142184993","https://openalex.org/W2142709610","https://openalex.org/W2144431766","https://openalex.org/W2145481747","https://openalex.org/W2158608719","https://openalex.org/W2169656611","https://openalex.org/W2183107537","https://openalex.org/W2194342315","https://openalex.org/W2203480037","https://openalex.org/W2271663961","https://openalex.org/W2280299758","https://openalex.org/W2333241266","https://openalex.org/W2397170433","https://openalex.org/W2443548094","https://openalex.org/W2516690439","https://openalex.org/W2521226389","https://openalex.org/W2532470837","https://openalex.org/W2576109111","https://openalex.org/W2752424603","https://openalex.org/W2766024102","https://openalex.org/W2767336741","https://openalex.org/W2768892314","https://openalex.org/W2768964978","https://openalex.org/W2782685575","https://openalex.org/W2785190283","https://openalex.org/W2811247652","https://openalex.org/W2888262269","https://openalex.org/W2894608512","https://openalex.org/W2918786033","https://openalex.org/W2960184952","https://openalex.org/W2990374102","https://openalex.org/W2999958881","https://openalex.org/W3034162969","https://openalex.org/W3044843687","https://openalex.org/W3159844184","https://openalex.org/W3163984666","https://openalex.org/W3200072667","https://openalex.org/W4206965390","https://openalex.org/W4211040114","https://openalex.org/W4211045835","https://openalex.org/W4281624193","https://openalex.org/W4283815217","https://openalex.org/W4286250189","https://openalex.org/W4286308881","https://openalex.org/W4293871533","https://openalex.org/W4307635342","https://openalex.org/W4310772623","https://openalex.org/W4379536529"],"related_works":["https://openalex.org/W2807568660","https://openalex.org/W4249717762","https://openalex.org/W3049368451","https://openalex.org/W4285097218","https://openalex.org/W2592953803","https://openalex.org/W2797968236","https://openalex.org/W2994744934","https://openalex.org/W4200550927","https://openalex.org/W2889258202","https://openalex.org/W4399381314"],"abstract_inverted_index":{"Tumorzellen":[0,127,147],"sind":[1],"in":[2,71,76,126,141,161,193],"der":[3,42,47,56,106,123,136,146,188,194],"Lage":[4],"einer":[5,89,142,172],"Immunantwort":[6],"durch":[7,61,94],"die":[8,37,52,82,140,151,169,199],"\u00dcberexpression":[9],"von":[10,54,201],"Immuncheckpoint-Liganden":[11],"zu":[12,204],"entkommen.":[13],"Ein":[14],"Beispiel":[15],"hierf\u00fcr":[16],"ist":[17],"CD47,":[18],"das":[19,103],"nach":[20],"Bindung":[21],"an":[22,138],"den":[23],"Rezeptor":[24],"signal":[25],"regulatory":[26],"protein":[27],"alpha,":[28],"kurz":[29],"SIRP\u03b1,":[30],"myeloischer":[31],"Zellen,":[32],"wie":[33],"Makrophagen":[34],"und":[35,68,84,163,174],"Neutrophilen,":[36],"Immunzellen":[38],"inhibiert.":[39],"Im":[40],"Rahmen":[41],"Arbeit":[43],"wurde":[44],"gezeigt,":[45],"dass":[46],"Einsatz":[48],"des":[49,63,114,159],"CD47-Blockadeantik\u00f6rpers":[50],"hu5F9-IgG2\u03c3":[51],"Eliminierung":[53,145],"Zellen":[55,203],"akuten":[57],"lymphoblastischen":[58],"T-Zellleuk\u00e4mie":[59],"(T-ALL-Zellen)":[60],"Varianten":[62],"CD38-gerichteten":[64],"Antik\u00f6rpers":[65],"Daratumumab":[66],"(IgG1":[67],"IgA2)":[69],"sowohl":[70],"Makrophagen-vermittelten":[72],"ADCP-Experimenten":[73],"als":[74],"auch":[75],"Neutrophilen-vermittelten":[77],"ADCC-Versuchen":[78],"verst\u00e4rkt.":[79],"Zudem":[80],"konnte":[81],"Makrophagen-":[83],"Neutrophilen-vermittelte":[85],"Phagozytose":[86],"bzw.":[87,182],"Lyse":[88],"T-ALL-Zelllinie":[90],"mit":[91,97,128],"geringer":[92],"CD38-Expression":[93,107],"vorangegangene":[95],"Behandlung":[96],"Retins\u00e4ure":[98],"(all-trans":[99],"retinoic":[100],"acid,":[101],"ATRA),":[102],"einen":[104],"Anstieg":[105],"bewirkt,":[108],"verbessert":[109],"werden.":[110,120],"Die":[111,121],"CD47-SIRP\u03b1-Achse":[112],"kann":[113],"Weiteren":[115],"auf":[116],"indirektem":[117],"Wege":[118],"unterbunden":[119],"Inhibition":[122],"Golgi-residenten":[124],"Isoglutaminylzyklase":[125],"dem":[129],"spezifischen":[130],"Inhibitor":[131],"SEN177":[132],"erzielte":[133],"eine":[134,157,186,190],"Reduktion":[135],"SIRP\u03b1-Bindung":[137],"Karzinomzellen,":[139],"verbesserten":[143],"antik\u00f6rpervermittelten":[144],"resultierte.":[148],"Hierbei":[149],"wurden":[150],"EGFR-gerichteten":[152],"Antik\u00f6rper":[153],"Cetuximab,":[154],"Panitumumab":[155,177],"sowie":[156],"IgA2-Variante":[158],"Cetuximab":[160],"Makrophagen-ADCP":[162],"Neutrophilen-ADCC":[164],"Versuchen":[165],"untersucht.":[166],"Vor":[167],"allem":[168],"Kombination":[170],"aus":[171],"SEN177-Behandlung":[173],"Cetuximab-IgA2":[175],"oder":[176],"(IgG2)":[178],"generierte":[179],"vielversprechende":[180],"Lyse-":[181],"Phagozytoseraten.":[183],"Folglich":[184],"stellt":[185],"Blockade":[187],"CD47-SIRP\u03b1-Interaktion":[189],"interessante":[191],"M\u00f6glichkeiten":[192],"antik\u00f6rperbasierten":[195],"Tumorimmuntherapie":[196],"dar,":[197],"um":[198],"Aktivit\u00e4t":[200],"myeloischen":[202],"erh\u00f6hen.":[205]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7052897272","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-10-10T00:00:00"}
